Topics

NICE Recommends Olaparib Maintenance in Relapsed, Platinum-Sensitive Ovarian Cancer

16:45 EST 15 Jan 2020 | OncLive

The National Institute for Health and Care Excellence has recommended the use of olaparib as a maintenance treatment in adults with relapsed, platinum-sensitive, high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer.

Original Article: NICE Recommends Olaparib Maintenance in Relapsed, Platinum-Sensitive Ovarian Cancer

NEXT ARTICLE

More From BioPortfolio on "NICE Recommends Olaparib Maintenance in Relapsed, Platinum-Sensitive Ovarian Cancer"

Quick Search

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...